What the company does
Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells in Spain and internationally. It offers Clarivine that activates skin's regeneration processes; Quora Noni biomics for rejuvenating the skin microbiota; Deobiome Noni, a prebiotic deodorant to reduce the generation of body odour; Sarcoslim Re-Shape, an active ingredient to reduce fat on tissue; Capilia Longa that improves density in hair, eyebrows, and eyelashes; and Luminia Granatum that brightens skin, whitens dark spots, evens skin tone, and protects against oxidative stress. The company also provides Baolift that improves muscle tone and facial complexion; Elaya …
What the weekly tape is saying
VYT closed the latest completed week at 16.20 EUR. The 4-week return is 0.0% and the 12-week return is 5.9%. Trend Signal is active, Market Dynamics is -0.50. Setup signature: Balanced read with a 53/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 13.02 EUR
- Vs Trend Line
- 24.4%
- Fair Value
- 5.33 EUR
- Vs Fair Value
- 204.1%
- 52W High
- 20.60 EUR
- 52W Low
- 3.80 EUR
- Drawdown
- -21.4%
- Range Position
- 73.8%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 63 weeks
- 52W Active Weeks
- 52
- 52W Active Breadth
- 100.0%
- Sector Scope
- ES Healthcare
- Sector Rank
- 10 of 14
- Sector Percentile
- 30.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
ES Healthcare
- Tracked Peers
- 14
- 4W Rank
- 7 of 14
- Avg 1W
- -3.1%
- Avg 4W
- -0.9%
- Trend Breadth
- 42.9%
- Positive MD
- 57.1%
ES Biotechnology
- Tracked Peers
- 5
- 4W Rank
- 2 of 5
- Avg 1W
- -7.5%
- Avg 4W
- -4.0%
- Trend Breadth
- 60.0%
- Positive RS
- 20.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.50
- 4W MD Change
- -140.4%
- Relative Strength
- 47.45
- 4W RS Change
- -33.3%
- Expectation
- Positive
- Probability
- 58.57%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 16.6K
- 13W Average
- 50.6K
- 52W Average
- 51.4K
- Vs 13W
- 0.3x
- Vs 52W
- 0.3x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 8.8%
- 52W Volatility
- 7.8%
- Upside Weeks
- 31
- Downside Weeks
- 20
- Downside Breadth
- 38.5%
- Avg Gain / Loss
- 7.8% / -4.2%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- MCE
- Country
- ES
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- EUR
- Market Cap
- 120.3M
Opportunity signals
- Trend Signal is active with a 63-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
Risk signals
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 16.20 EUR | -2.1% | 13.02 EUR | 5.33 EUR | -0.50 | 47.45 | 16.6K | On |
| 5 Jun 2026 | 16.55 EUR | 0.9% | 12.75 EUR | 5.24 EUR | -0.32 | 57.06 | 25.0K | On |
| 29 May 2026 | 16.40 EUR | 2.5% | 12.41 EUR | 5.16 EUR | 0.16 | 58.75 | 18.4K | On |
| 22 May 2026 | 16.00 EUR | -1.2% | 12.09 EUR | 5.07 EUR | 0.69 | 61.76 | 43.6K | On |
| 15 May 2026 | 16.20 EUR | -12.4% | 11.77 EUR | 4.99 EUR | 1.25 | 71.16 | 41.4K | On |
| 8 May 2026 | 18.50 EUR | -6.6% | 11.43 EUR | 4.91 EUR | 1.71 | 97.49 | 76.9K | On |
| 1 May 2026 | 19.80 EUR | 1.0% | 11.02 EUR | 4.81 EUR | 1.86 | 119.01 | 36.1K | On |
| 24 Apr 2026 | 19.60 EUR | 11.0% | 10.55 EUR | 4.71 EUR | 1.98 | 125.30 | 65.9K | On |
| 17 Apr 2026 | 17.65 EUR | -4.3% | 10.08 EUR | 4.60 EUR | 1.96 | 101.00 | 91.8K | On |
| 10 Apr 2026 | 18.45 EUR | 8.5% | 9.69 EUR | 4.51 EUR | 1.94 | 119.83 | 43.3K | On |
| 3 Apr 2026 | 17.00 EUR | 13.3% | 9.27 EUR | 4.41 EUR | 1.74 | 117.06 | 70.4K | On |
| 27 Mar 2026 | 15.00 EUR | -2.0% | 8.90 EUR | 4.33 EUR | 1.38 | 106.64 | 58.8K | On |
| 20 Mar 2026 | 15.30 EUR | 21.4% | 8.60 EUR | 4.25 EUR | 1.38 | 118.56 | 69.7K | On |
| 13 Mar 2026 | 12.60 EUR | 12.5% | 8.28 EUR | 4.17 EUR | 1.40 | 82.20 | 56.8K | On |